Smith K, Downie S, Barua J M, Watt P W, Scrimgeour C M, Rennie M J
Department of Anatomy and Physiology, University of Dundee, Scotland, United Kingdom.
Am J Physiol. 1994 Apr;266(4 Pt 1):E640-4. doi: 10.1152/ajpendo.1994.266.4.E640.
Recently, we demonstrated increased incorporation of [13C]valine tracer into muscle protein after administration of a flooding dose of L-leucine. We have now investigated the possibility of a similar effect on albumin synthesis in the same group of volunteers. We gave L-[1-13C]leucine (20 atom%, 0.05 g/kg) during the final 90 min of a 7.5-h primed constant infusion of L-[1-13C]valine (99 atom%, 1.5 mg/kg prime constant infusion of 1.5 mg.kg-1.h-1) in healthy male volunteers in the postabsorptive state. Blood samples, taken at 0.5- to 1-h intervals during the constant infusion and at 5- to 30-min intervals during the application of the flooding dose, were analyzed for the concentration and 13C enrichment of leucine, valine, and their ketoacids. Albumin was isolated and hydrolyzed, and the enrichments of incorporated valine and leucine were compared with the mean enrichment of various possible precursor pools to calculate the apparent rate of albumin protein synthesis according to the standard procedures. During constant infusion of [13C]valine tracer the rate of albumin synthesis (measured using alpha-ketoisovalerate labeling as a surrogate for the true precursor) was 0.250 +/- 0.041%h (SD), a value identical to that routinely obtained using constant leucine tracer infusion and alpha-ketoisocaproate labeling. During the application of the flooding dose of leucine, the rate of incorporation of tracer [13C]valine into albumin increased by 73% to 0.433 +/- 0.129%/h (P < 0.05); the apparent protein synthetic rate calculated from the incorporation of leucine applied during the flood was 0.402 +/- 0.057 (P < 0.001). These results raise further doubts about the validity of the flooding dose method for the measurement of rates of human protein synthesis.
最近,我们证明在给予大剂量L-亮氨酸后,[13C]缬氨酸示踪剂掺入肌肉蛋白的量增加。我们现在研究了对同一组志愿者白蛋白合成产生类似影响的可能性。在空腹状态下的健康男性志愿者中,在7.5小时的L-[1-13C]缬氨酸(99原子%,1.5毫克/千克初始剂量,1.5毫克·千克-1·小时-1持续输注)的初始持续输注的最后90分钟内给予L-[1-13C]亮氨酸(20原子%,0.05克/千克)。在持续输注期间以0.5至1小时的间隔以及在给予大剂量期间以5至30分钟的间隔采集血样,分析亮氨酸、缬氨酸及其酮酸的浓度和13C富集情况。分离并水解白蛋白,将掺入的缬氨酸和亮氨酸的富集情况与各种可能前体池的平均富集情况进行比较,以根据标准程序计算白蛋白蛋白质合成的表观速率。在持续输注[13C]缬氨酸示踪剂期间,白蛋白合成速率(使用α-酮异戊酸标记作为真正前体的替代物进行测量)为0.250±0.041%/小时(标准差),该值与使用持续亮氨酸示踪剂输注和α-酮异己酸标记常规获得的值相同。在给予亮氨酸大剂量期间,示踪剂[13C]缬氨酸掺入白蛋白的速率增加了73%,达到0.433±0.129%/小时(P<0.05);根据大剂量期间给予的亮氨酸掺入情况计算的表观蛋白质合成速率为0.402±0.057(P<0.001)。这些结果进一步质疑了大剂量法用于测量人体蛋白质合成速率的有效性。